Gregory A Gould's Net Worth
$921 Thousand
Who is Gregory A Gould?
Gregory A Gould does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NewAge, Inc., AYTU BIOSCIENCE, INC, INTEGRATED BIOPHARMA INC, CytoDyn Inc., Ampio Pharmaceuticals, Inc., SERACARE LIFE SCIENCES INC, Charlotte's Web Holdings, Inc., ATRIX LABORATORIES INC, and COLORADO MEDTECH INC.
SEC CIK
Gregory A Gould's CIK is 0001252905
Past Insider Trading and Trends
2018 was Gregory A Gould's most active year for acquiring shares with 14 total transactions. Gregory A Gould's most active month to acquire stocks was the month of October. 2018 was Gregory A Gould's most active year for disposing of shares, totalling 12 transactions. Gregory A Gould's most active month to dispose stocks was the month of October. 2004 saw Gregory A Gould paying a total of $2,053,200.00 for 75,000 shares, this is the most they've acquired in one year. In 2021 Gregory A Gould cashed out on 99,617 shares for a total of $233,479.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NewAge, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.08% | -73.11K |
$2.24 | -$163,766.40 | 331.25K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| -6.15% | -26.51K |
$2.63 | -$69,713.41 | 404.37K |
Jan 5
| |||
Form 4
| -2.17% | -9.56K |
$3.16 | -$30,222.24 | 430.87K |
Dec 10
| |||
Form 4
| -2.13% | -9.56K |
$2.72 | -$26,014.08 | 440.44K |
Oct 22
| |||
Form 4
| +28.57% | 100K |
—
|
—
| 450K |
Dec 10
| |||
Form 4
|
∞
| 350K |
—
|
—
| 350K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AYTU BIOSCIENCE, INC (AYTU) Snapshot price: $2.5488
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| +24.37% | 66.67K |
$0.75 | $49,999.50 | 340.23K |
Feb 27
| |||
Form 4
| +32.22% | 66.67K |
$1.50 | $99,999.00 | 273.56K |
Nov 2
| |||
Form 4
| +25.39% | 41.9K |
—
|
—
| 206.9K |
Aug 2
| |||
Form 4
|
∞
| 165K |
—
|
—
| 165K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTEGRATED BIOPHARMA INC (INBP) Snapshot price: $0.200525
Sr VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytoDyn Inc. (CYDY) Snapshot price: $0.1599
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 19.18K |
—
|
—
| 19.18K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -19.18K |
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +19.47% | 3.13K |
—
|
—
| 19.18K |
May 31 - Jun 1
| |||
Form 4
| +18.45% | 2.5K |
—
|
—
| 16.05K |
Feb 28
| |||
Form 4
| +13.03% | 1.56K |
—
|
—
| 13.55K |
Nov 30
| |||
Form 4
| +37.13% | 3.25K |
—
|
—
| 11.99K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +74.86% | 3.74K |
—
|
—
| 8.74K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20 - Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ampio Pharmaceuticals, Inc. (AMPE) Snapshot price: $1.7
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||